Jazz’s Midphase Tremor Drug Misses Mark, Future Uncertainby Lilu Anderson 20.06.2024Jazz Pharmaceuticals hits a hurdle as its essential tremor drug trial misses primary endpoint. Awaiting Parkinson's trial results for future ...